How do you pay?

How to pay the least

From

$239.52 for 30 tablets

Generic eltrombopag olamine with the free Team Cuban Card, at pharmacies that take it. Pick the strength on your label above for its own price.

  1. Get the free Team Cuban Card. It costs nothing to sign up.See the price and get the card 
  2. At a pharmacy that takes it, show the card and ask for generic eltrombopag olamine.Find a pharmacy that takes it 

A regular generic has the same active ingredient as Promacta, and the FDA requires it to work the same way.

Compare every option

Question
Brand namePromacta
Authorized genericeltrombopag olamine
Regular genericeltrombopag olamine
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
From$239.52for 30 tablets at Team Cuban Card
Same as Promacta?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameThe maker’s card

Novartis Oncology Universal Co-pay Program

Savings card from Novartis

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $15,000 a year off your co-pay.

Sign up on us.promacta.com 

Or call 1-877-577-7756.

In the maker’s words

“Eligible patients with private insurance may pay $0 per month for PROMACTA…”

From the maker’s offer on us.promacta.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Promacta itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic eltrombopag olamine, lowest first.

Pick up in store

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericMakers and their savings cards

9 companies sell a generic of Promacta that the FDA rates a substitute. A pharmacy fills whichever one it stocks. 4 of them have their own savings cards or programs, listed first. Each works only with that maker’s version. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Novadoz PharmaceuticalsTablet 12.5 mg, 25 mg, 50 mg, 75 mg

    Has a dye: FD&C Blue No. 2 · Made by MSN Laboratories

    Novadoz Eltrombopag Copay Card

    With commercial insurance as little as $7,500

    Sign up on novadozpharma.com

    Or call 1-877-274-3244.

    In the maker’s words

    “This offer is valid for a maximum savings of $7500 per calendar year.”

    How it looks, what’s in it, NDCs

    12.5 mg White, round, 6 mm, marked “ME / 12”

    PackageNDC
    Bottle of 3072205-156-30

    25 mg Orange, round, 7 mm, marked “ME / 13”

    PackageNDC
    Bottle of 3072205-157-30

    50 mg Blue, round, 9 mm, marked “ME / 14”

    PackageNDC
    Bottle of 1972205-158-19
    Bottle of 3072205-158-30

    75 mg Brown, round, 10 mm, marked “ME / 15”

    PackageNDC
    Bottle of 3072205-159-30

    Inactive ingredients: magnesium stearate, mannitol, microcrystalline cellulose 102, povidone k30, sodium starch glycolate type a, hypromellose 2910 (5 mpa.s), polyethylene glycol 400, titanium dioxide, hypromellose 2910 (6 mpa.s), polyethylene glycol 6000, ferric oxide yellow, ferric oxide red, FD&C Blue No. 2, polyethylene glycol 3350, ferrosoferric oxide

    FDA label

  • Somerset TherapeuticsTablet 12.5 mg, 25 mg, 50 mg, 75 mg

    Has a dye: FD&C Blue No. 2 aluminum lake

    Somerset Copay Assistance Program

    For eltrombopag tablets 12.5, 25, 50, 75 mg

    With commercial insurance as little as $0 a month

    Sign up on somersetpharma.com

    In the maker’s words

    “Eligible cash paying and commercially insured patients may receive their monthly prescription for $0.”

    How it looks, what’s in it, NDCs

    12.5 mg White, round, 6 mm, marked “I”

    PackageNDC
    Bottle of 3070069-837-01

    25 mg Orange, round, 8 mm, marked “II”

    PackageNDC
    Bottle of 3070069-838-01

    50 mg Blue, round, 10 mm, marked “III”

    PackageNDC
    Bottle of 3070069-839-01

    75 mg Red, round, 12 mm, marked “IV”

    PackageNDC
    Bottle of 3070069-840-01

    Inactive ingredients: magnesium stearate, cellulose, microcrystalline, povidone, sodium starch glycolate type a potato, hypromellose 2910 (5 mpa.s), titanium dioxide, mannitol, isomalt, calcium silicate, triacetin, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, blue 1 lake, FD&C Blue No. 2 aluminum lake

    FDA label

  • Zydus LifesciencesTablet 12.5 mg, 25 mg, 50 mg, 75 mg

    Has a dye: FD&C Blue No. 2--aluminum lake

    Zydus Copay Savings Program

    With commercial insurance as little as $0

    Print the card (PDF)

    See the offer on zydususa.com

    In the maker’s words

    “Eligible patients who have commercial insurance, pay as little as $0 co-pay per prescription.”

    How it looks, what’s in it, NDCs

    12.5 mg White to light blue, round, 5 mm, marked “I”

    PackageNDC
    Bottle of 3070710-1395-3

    25 mg Light yellow, round, 7 mm, marked “I7”

    PackageNDC
    Bottle of 3070710-1396-3

    50 mg Light blue, round, 9 mm, marked “112”

    PackageNDC
    Bottle of 1470710-1397-7
    Bottle of 3070710-1397-3

    75 mg Light purple, round, 11 mm, marked “I17”

    PackageNDC
    Bottle of 3070710-1398-3

    Inactive ingredients: hypromellose 2910 (6 mpa.s), microcrystalline cellulose 101, polyethylene glycol 400, povidone k30, sodium starch glycolate type a potato, sodium stearyl fumarate, titanium dioxide, xylitol, ferric oxide red, ferric oxide yellow, FD&C Blue No. 2--aluminum lake, ferrosoferric oxide

    FDA label

  • Camber PharmaceuticalsPowder 12.5 mg, 25 mg · Tablet 12.5 mg, 25 mg, 50 mg, 75 mg

    Has dyes: FD&C Blue No. 2, FD&C Yellow No. 6 · Made by Annora Pharma and Hetero Labs

    Camber Copay Assistance Program (Camber Pharmaceuticals Co-Pay Program)

    “To help alleviate the burden some drug prices create, Camber has made a copayment assistance program to help offset rising drug prices.” (patients not covered by any federal or state healthcare program (Medicare, Medicaid, Medigap, VA/DOD, TRICARE excluded); page says 'All non-excluded patients are eligible')

    Sign up

    How it looks, what’s in it, NDCs

    12.5 mg

    PackageNDC
    Kit of 3031722-300-32

    12.5 mg Off-white, round, 8 mm, marked “H / E10”

    PackageNDC
    Bottle of 3031722-841-30

    25 mg

    PackageNDC
    Kit of 3031722-301-32

    25 mg Beige, round, 10 mm, marked “H / E11”

    PackageNDC
    Bottle of 3031722-842-30

    50 mg Off-white, round, 10 mm, marked “H / E12”

    PackageNDC
    Bottle of 1431722-843-14
    Bottle of 3031722-843-30

    75 mg Off-white to light yellow, round, 10 mm, marked “H / E13”

    PackageNDC
    Bottle of 3031722-844-30

    Inactive ingredients: mannitol, sucralose, xanthan gum, microcrystalline cellulose 102, povidone k30, sodium starch glycolate type a potato, magnesium stearate, titanium dioxide, hypromellose 2910 (3 mpa.s), polyethylene glycol 400, polysorbate 80, hypromellose 2910 (6 mpa.s), microcrystalline cellulose 101, FD&C Yellow No. 6, FD&C Blue No. 2, ferric oxide yellow

    FDA label

  • Amneal PharmaceuticalsTablet 12.5 mg, 25 mg, 50 mg, 75 mg

    Has dyes: D&C Red No. 27, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2

    How it looks, what’s in it, NDCs

    12.5 mg White to off-white, round, 5 mm, marked “C9”

    PackageNDC
    Bottle of 3060219-1417-3

    25 mg Orange, round, 7 mm, marked “A25”

    PackageNDC
    Bottle of 3060219-1416-3

    50 mg Blue, round, 9 mm, marked “A26”

    PackageNDC
    Bottle of 3060219-1415-3

    75 mg Light brown to brown, round, 11 mm, marked “AC50”

    PackageNDC
    Bottle of 3060219-1414-3

    Inactive ingredients: hypromellose, magnesium stearate, mannitol, microcrystalline cellulose, polyethylene glycol 6000, povidone k30, sodium starch glycolate type a potato, titanium dioxide, D&C Red No. 27, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, ferric oxide red, ferric oxide yellow, ferrosoferric oxide

    FDA label

  • Biocon PharmaTablet 12.5 mg, 25 mg, 50 mg, 75 mg
    How it looks, what’s in it, NDCs

    12.5 mg Light gray to gray, round, 6 mm, marked “12 / 5 / VT”

    PackageNDC
    Bottle of 3070377-183-11

    25 mg Off-white to white, round, 7 mm, marked “EO / 25 / VT”

    PackageNDC
    Bottle of 3070377-184-11
    Bottle of 8470377-184-12

    50 mg Light Brown color, round, 9 mm, marked “EO / 50 / VT”

    PackageNDC
    Bottle of 1470377-185-11
    Bottle of 3070377-185-12
    Bottle of 8470377-185-13

    75 mg Brown, round, 11 mm, marked “EO / 75 / VT”

    PackageNDC
    Bottle of 3070377-186-11
    Bottle of 8470377-186-12

    Inactive ingredients: magnesium stearate, mannitol, cellulose, microcrystalline, povidone, sodium starch glycolate type a potato, hypromellose, polyethylene glycol 400, titanium dioxide, polysorbate 80, ferric oxide yellow, ferric oxide red, ferrosoferric oxide

    FDA label

  • Dr. Reddy’s LaboratoriesTablet 12.5 mg, 25 mg, 50 mg, 75 mg

    Has lactose

    How it looks, what’s in it, NDCs

    12.5 mg Light brown to brown, round, 5 mm, marked “EL / I”

    PackageNDC
    Bottle of 3043598-151-30

    25 mg Brown to dark brown, round, 7 mm, marked “EL / 2”

    PackageNDC
    Bottle of 3043598-730-30

    50 mg Brown to reddish brown, round, 9 mm, marked “EL / 3”

    PackageNDC
    Bottle of 3043598-731-30

    75 mg Light brown to brown, round, 10 mm, marked “EL / 4”

    PackageNDC
    Bottle of 3043598-732-30

    Inactive ingredients: magnesium stearate, mannitol, cellulose, microcrystalline, povidone k30, sodium starch glycolate type a, silicon dioxide, lactose monohydrate, polyethylene glycol 4000, polyvinyl alcohol, talc, ferric oxide red, ferrosoferric oxide, ferric oxide yellow

    FDA label

  • Hikma PharmaceuticalsTablet 12.5 mg, 25 mg, 50 mg, 75 mg
    Packages and NDCs

    12.5 mg

    PackageNDC
    Bottle of 300054-0962-13

    25 mg

    PackageNDC
    Bottle of 300054-0963-13

    50 mg

    PackageNDC
    Bottle of 300054-0964-13

    75 mg

    PackageNDC
    Bottle of 300054-0965-13
  • Teva PharmaceuticalsTablet 12.5 mg, 25 mg, 50 mg, 75 mg

    Made by Actavis LLC An Indirect Wholly Owned Sub Of Teva Pharmaceuticals

    Packages and NDCs

    12.5 mg

    PackageNDC
    Bottle of 300480-4015-56

    25 mg

    PackageNDC
    Bottle of 300480-4210-56

    50 mg

    PackageNDC
    Bottle of 300480-2600-56

    75 mg

    PackageNDC
    Bottle of 300480-4031-56

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

What to say at the pharmacy

“Before you fill my Promacta, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

PROMACTA is a thrombopoietin receptor agonist indicated:

  • for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. PROMACTA should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding.
  • for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. PROMACTA should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.
  • in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
  • for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

Limitations of Use:

  • PROMACTA is not indicated for the treatment of patients with myelodysplastic syndrome (MDS).
  • Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for treatment of chronic hepatitis C infection.

Source: the FDA label for Promacta (Novartis Pharmaceuticals Corporation), December 18, 2025. Full label on DailyMed 

Good to know